Loading…
Nuvalent, Inc. is projected to rise to $146.58 by 2027, a +18% move from its current price of $123.90. NUVL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $121.90 | $123.93 | $126.00 | +0.02% |
| Jul 15 | $121.09 | $123.96 | $126.90 | +0.05% |
| Jul 16 | $120.49 | $123.99 | $127.60 | +0.07% |
| Jul 17 | $119.98 | $124.02 | $128.19 | +0.10% |
| Jul 18 | $119.54 | $124.05 | $128.73 | +0.12% |
| Jul 19 | $119.15 | $124.08 | $129.21 | +0.14% |
| Jul 20 | $118.79 | $124.11 | $129.66 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $118.79 | $124.11 | $129.66 | +0.17% |
| Week 2 | $116.85 | $124.32 | $132.26 | +0.34% |
| Week 3 | $115.43 | $124.53 | $134.34 | +0.51% |
| Week 4 | $114.28 | $124.74 | $136.16 | +0.68% |
| Week 5 | $113.29 | $124.95 | $137.80 | +0.85% |
| Week 6 | $112.43 | $125.16 | $139.33 | +1.02% |
| Week 7 | $111.66 | $125.37 | $140.77 | +1.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer therapies. Its lead product candidates are Zidesamtinib (NVL-520), a novel ROS1-selective inhibitor, Neladalkib (NVL-655), a brain-penetrant ALK-selective inhibitor, and NVL-330, a brain-penetrant HER2-selective inhibitor designed to treat HER2ex20-driven tumors.
Nuvalent has a strategic partnership with Guardant Health, Inc. to develop companion diagnostics therapies. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Nuvalent, Inc. (NUVL) operates in the healthcare space, focused on cancer therapies. The current price is $123.83, and the market cap is $9.8B, with a market position ranked at 929.
The near-term outlook reflects a neutral to bullish trajectory in the forecast horizon, starting with a 2026 average of $123.83 and a 2026 range from $88.49 to $163.40. The longer-range forecast points to substantial upside, including a 2030 average of $233.84 and a 2050 average of $1,130.43, with corresponding max values of $318.76 and $1,848.36 respectively.
A major floor 38.1% below — a decisive break under it would weaken the trend.
The nearest floor, 28.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 19.1% above — clearing it would confirm fresh momentum.
Key NUVL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NUVL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $123.80 | Buy | $123.80 | Buy |
| MA 10 | $123.69 | Buy | $123.38 | Buy |
| MA 20 | $123.55 | Buy | $120.85 | Buy |
| MA 50 | $110.75 | Buy | $114.14 | Buy |
| MA 100 | $106.39 | Buy | $108.86 | Buy |
| MA 200 | $102.76 | Buy | $102.48 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.45 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 153.98 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.67 | Sell |
| ROC (12) | 0.37 | Buy |
| Bollinger %B (20,2) | 0.99 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.62 | Buy |
| Awesome (5,34) | 9.07 | Buy |
| Ultimate (7,14,28) | 88.70 | Sell |
| Momentum (10) | 0.37 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 123.89 | Buy |
| ADX (14) | 30.83 | Buy |
| ATR (14) | 1.11 | Info |
The 30-day technical picture leans bullish with a bullish sentiment reading. The RSI(14) is 70, and both the 50-day and 200-day simple moving averages stand at $110.75 and $102.76 respectively. The price sits above a support level of $88.49 and below a resistance level of $123.90. The 30-day price range spans from $111.03 to $138.10.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $88.49 | $123.90 | $163.00 | 0% | Neutral | |
| $120.06 | $146.58 | $187.10 | +18% | Neutral | |
| $129.61 | $161.22 | $211.36 | +30% | Bullish | |
| $146.20 | $184.66 | $247.25 | +49% | Bullish | |
| $182.74 | $233.93 | $318.85 | +89% | Bullish | |
| $200.73 | $260.10 | $360.14 | +110% | Bullish | |
| $205.83 | $269.72 | $378.77 | +118% | Bullish | |
| $228.19 | $302.17 | $429.83 | +144% | Bullish | |
| $234.15 | $313.15 | $450.78 | +153% | Bullish | |
| $247.63 | $334.31 | $486.60 | +170% | Bullish | |
| $361.12 | $508.49 | $775.62 | +310% | Bullish | |
| $746.94 | $1,128.02 | $1,844.37 | +810% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $88.49 | $123.90 | $144.54 | +0.00% |
| August 2026 | $104.53 | $122.33 | $146.24 | -1.27% |
| September 2026 | $107.70 | $126.65 | $152.60 | +3.53% |
| October 2026 | $109.31 | $129.08 | $156.56 | +1.92% |
| November 2026 | $109.05 | $129.22 | $157.59 | +0.10% |
| December 2026 | $111.85 | $132.97 | $163.00 | +2.91% |
Click any year to see its month-by-month NUVL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, NUVL could reach as high as $163.00, with a base case around $123.90 and support toward $88.49 — roughly 0% from $123.90. Price action looks broadly range-bound.
Expect NUVL to range from $120.06 to $187.10 through 2027. The $146.58 average target implies a +18% move from current prices. That is up +18% on the projected 2026 average. A consolidation phase looks the most probable path here.
The NUVL price prediction for 2028 points to an average of $161.22 (low $129.61, high $211.36) — a potential gain of +30% on today's $123.90. Momentum favours further upside here.
In 2029, NUVL is projected to trade between $146.20 and $247.25, averaging $184.66 — a potential gain of +49% from today's $123.90. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Nuvalent, Inc.'s 2030 outlook centres on $233.93, within a $182.74 to $318.85 range. That is up +27% on the projected 2029 average. That marks a +89% change versus current levels. Momentum favours further upside here.
By 2031, NUVL could reach as high as $360.14, with a base case around $260.10 and support toward $200.73 — roughly +110% from $123.90. Buyers look set to stay in control over this stretch.
Expect NUVL to range from $205.83 to $378.77 through 2032. The $269.72 average target implies a +118% move from current prices. That is up +4% on the projected 2031 average. Momentum favours further upside here.
The NUVL price prediction for 2033 points to an average of $302.17 (low $228.19, high $429.83) — a potential gain of +144% on today's $123.90. Buyers look set to stay in control over this stretch.
In 2034, NUVL is projected to trade between $234.15 and $450.78, averaging $313.15 — a potential gain of +153% from today's $123.90. That is up +4% on the projected 2033 average. Momentum favours further upside here.
Nuvalent, Inc.'s 2035 outlook centres on $334.31, within a $247.63 to $486.60 range. That is up +7% on the projected 2034 average. That marks a +170% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, NUVL could reach as high as $775.62, with a base case around $508.49 and support toward $361.12 — roughly +310% from $123.90. Momentum favours further upside here.
Expect NUVL to range from $746.94 to $1,844.37 through 2050. The $1,128.02 average target implies a +810% move from current prices. That is up +122% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NUVL today (≈ 8.071025 NUVL) could be worth
$9,104.28
+$8,104.28 (+810%) by 2050 · US Dollar
Based on the average projected NUVL price of $1,128.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NUVLwould be worth at today's price.
$1,000 invested in NUVL on Jul 10, 2025 (≈ 12.18472 NUVL) would be worth
$1,509.69
+$509.69 (+51.0%) today · 1.51× · US Dollar
Based on a NUVL entry price of $82.07 vs. today's $123.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $123.73 | $1,001.37 | +0.1% |
| 1 month ago | $123.35 | $1,004.46 | +0.4% |
| 3 months ago | $102.74 | $1,205.96 | +20.6% |
| 6 months ago | $99.16 | $1,249.5 | +24.9% |
| 1 year ago | $82.07 | $1,509.69 | +51.0% |
| All time (5.0y) ago | $18.75 | $6,608 | +560.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NUVL forecast.
Our base-case forecast reaches $250.00 around 2031.
Implied market cap at $250.00: $18.39B
Longer-term projections show a rising trajectory across key milestones. The 2026 forecast carries an average price of $123.83 with a min of $88.49 and a max of $163.40, yielding a neutral sentiment. From 2027 onward, the model envisions steadily higher averages and robust upside: 2027 avg $146.39 with ROI 18.2%, 2028 avg $161.03 with ROI 30%, 2029 avg $185.20 with ROI 49.6%, 2030 avg $233.84 with ROI 88.8%, 2031 avg $259.79 with ROI 109.8%, 2032 avg $270.03 with ROI 118.1%, 2033 avg $301.97 with ROI 143.9%, 2034 avg $312.96 with ROI 152.7%, 2035 avg $334.59 with ROI 170.2%, then 2040 avg $507.78 with ROI 310.1%, and 2050 avg $1,130.43 with ROI 812.9%.
These figures imply substantial upside over time, though they are estimates and not guarantees. The published path emphasizes a bullish long-term view, tempered by inherent forecasting uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average of $233.84 with a min of $182.65 and a max of $318.76, corresponding to an ROI of 88.8% along a bullish outlook.
Forecasts project positive returns starting in 2027 (ROI 18.2%), rising through 2028 (ROI 30%), 2029 (ROI 49.6%), 2030 (ROI 88.8%), 2031 (ROI 109.8%), 2032 (ROI 118.1%), 2033 (ROI 143.9%), 2034 (ROI 152.7%), 2035 (ROI 170.2%), then 2040 (ROI 310.1%), and 2050 (ROI 812.9%). These are estimates, not guarantees.
Yes. The 2030 max is $318.76, which exceeds $300, while the 2030 average is $233.84.
Current price is $123.83 and market cap is $9.8B; the rank is 929.
The 30-day technical picture is bullish with RSI(14) at 70. The SMA50 is $110.75 and the SMA200 is $102.76. Support is at $88.49 and resistance at $123.90, with a 30-day range of $111.03 to $138.10.
Nuvalent, Inc. Community Discussion
0Share your Nuvalent, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.